appScorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Biogen Pharmachem Industries Ltd
BIOGEN
Price Chart
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key MetricsEdit
Forecast & RatingsDetailed Forecast
Price
Price Upside
—
Earnings
Earnings Growth
—
Revenue
Rev. Growth
—
Company Profile
Sun Techno Overseas Ltd. invests and trades in shares and securities. It trades in commodities, including agro based and precious metals, and other goods in present and future markets.
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Holdings TrendDetailed holdings
Low Pledged Promoter HoldingLower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
Mutual Fund HoldingIncreasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock
In last 3 months, mutual fund holding of the company has almost stayed constant
Recent NewsAll news
Hmm, looks like data is unavailable here. Please come back after some timeRecent EventsAll events
Result
Biogen Pharmachem Industries Ltd - 531752 - Un-Audited Financial Result Quarter And Half Year Ended On 30Th September 2024 Pursuant To Regulation 33 Of The SEBI (LODR) Regulations, 2015. | Download
Biogen Pharmachem Industries Ltd - 531752 - Un-Audited Financial Result Quarter And Half Year Ended On 30Th September 2024 Pursuant To Regulation 33 Of The SEBI (LODR) Regulations, 2015. | Download
Board Meeting
Biogen Pharmachem Industries Ltd - 531752 - Board Meeting Outcome for Un-Audited Financial Result Quarter And Half Year Ended On 30Th September 2024 Pursuant To Regulation 33 Of The SEBI (LODR) Regulations, 2015. | Download
Biogen Pharmachem Industries Ltd - 531752 - Board Meeting Outcome for Un-Audited Financial Result Quarter And Half Year Ended On 30Th September 2024 Pursuant To Regulation 33 Of The SEBI (LODR) Regulations, 2015. | Download
Board Meeting
Biogen Pharmachem Industries Ltd - 531752 - Board Meeting Intimation for Compliance Of Regulation 29 Of SEBI (LODR) Regulations, 2015 - Intimation Of Board Meeting. | Download
Biogen Pharmachem Industries Ltd - 531752 - Board Meeting Intimation for Compliance Of Regulation 29 Of SEBI (LODR) Regulations, 2015 - Intimation Of Board Meeting. | Download
Total Promoter HoldingIncreasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant